INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT

Mastopathy is the most common disease in women, accounting for 90% of the flow of diseases in mammology. The etiology of fibrocystic mastopathy has not been fully elucidated, but many studied risk factors include endocrine disorders, particularly insulin resistance and thyroid disease.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-22
DOI
https://doi.org/10.5281/zenodo.17412060
Primary Topic
Breast Lesions and Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT

Zenodo (CERN European Organization for Nuclear Research)
Breast Lesions and Carcinomas
article

INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT

article en

Abstract

Mastopathy is the most common disease in women, accounting for 90% of the flow of diseases in mammology. The etiology of fibrocystic mastopathy has not been fully elucidated, but many studied risk factors include endocrine disorders, particularly insulin resistance and thyroid disease.

Zenodo (CERN European Organization for Nuclear Research)
Tashkent Medical Academy (UZ)
Good health and well-being
Openalex Percentile: Top 36%
Breast Lesions and Carcinomas
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS